Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Ami Organics
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Acutaas Chemicals

WEBSITE BSE:543349 NSE: ACUTAAS Inc. Year: 2007 Industry: Pharmaceuticals & Drugs My Bucket: Add Stock

₹2494.6 99.5 | 4.2%

Last updated: 15:51

Consolidated Standalone

Last updated: 15:51

Acutaas Chemicals Overview

Ami Organics Ltd engages in the R&D, manufacture, and sale of pharmaceutical intermediates in India. The enterprise offers about 450 pharma intermediates to be used in regulated and generic active pharmaceutical components for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-parkinson, anti-depressant, and anti-coagulant packages, in addition to new chemical entities. It additionally offers preservatives, such as parabens and parabens formulations for use in cosmetics, animal meals, and personal care industries; and special...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Acutaas Chemicals Key Financials

Market Cap ₹20424 Cr.

Stock P/E 127.3

P/B 13.4

Current Price ₹2494.6

Book Value ₹ 185.6

Face Value 5

52W High ₹2687.8

Dividend Yield 0.03%

52W Low ₹ 1041.1

Edit Ratio

Acutaas Chemicals Research See more...

Stocx User

Ami Organics Ltd

Acutaas Chemicals Share Price

₹ | |

Volume
Price

Acutaas Chemicals Quarterly Price

Quarterly Monthly
Show Value Show %

Acutaas Chemicals Peer Comparison

Acutaas Chemicals Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 172 166 225 177 247 275 308 207 306 393
Other Income 2 3 1 1 8 2 6 16 10 5
Total Income 174 170 226 178 255 277 314 223 316 398
Total Expenditure 148 140 182 147 198 206 224 156 211 243
Operating Profit 26 30 45 31 57 70 91 67 105 155
Interest 1 3 2 4 1 1 1 1 1 1
Depreciation 4 4 5 6 7 6 7 8 8 10
Exceptional Income / Expenses -32 0 -0 0 0 0 0 0 0 0
Profit Before Tax -10 24 37 20 50 63 83 58 96 145
Provision for Tax 7 6 12 5 12 18 20 14 24 38
Profit After Tax -17 18 26 15 38 45 63 44 72 106
Adjustments -2 -1 -1 -1 -0 -0 -0 0 0 2
Profit After Adjustments -19 17 25 14 37 45 62 44 72 108
Adjusted Earnings Per Share -2.6 2.3 3.4 1.7 4.6 5.5 3.8 5.4 8.8 13.2

Acutaas Chemicals Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 154 160 188 239 240 341 520 617 717 1007 1214
Other Income 3 0 3 0 3 1 3 4 7 17 37
Total Income 157 160 191 239 242 342 523 621 725 1024 1251
Total Expenditure 136 137 158 196 199 260 415 494 589 775 834
Operating Profit 21 23 33 42 44 82 108 127 136 249 418
Interest 3 3 3 5 6 6 6 2 6 6 4
Depreciation 1 1 2 3 4 4 10 12 16 27 33
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 -32 0 0
Profit Before Tax 18 19 28 35 35 72 91 112 82 216 382
Provision for Tax 5 7 10 12 7 18 20 29 33 56 96
Profit After Tax 13 12 18 23 27 54 72 83 49 160 285
Adjustments 0 0 0 0 0 0 0 0 -6 -2 2
Profit After Adjustments 13 12 19 23 27 54 72 83 43 159 286
Adjusted Earnings Per Share 2 1.9 2.9 3.7 4.4 2.9 9.9 11.4 5.8 9.7 31.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 40% 25% 33% 0%
Operating Profit CAGR 83% 32% 41% 0%
PAT CAGR 227% 30% 43% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 125% 67% NA% NA%
ROE Average 16% 13% 20% 29%
ROCE Average 20% 17% 22% 28%

Acutaas Chemicals Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 27 39 58 82 112 167 522 594 674 1310
Minority's Interest 0 0 0 0 0 0 0 0 9 10
Borrowings 16 15 32 22 20 73 1 1 114 0
Other Non-Current Liabilities -1 1 1 3 6 8 7 10 14 27
Total Current Liabilities 49 55 65 106 95 166 129 163 285 202
Total Liabilities 91 109 155 213 232 413 659 767 1096 1549
Fixed Assets 18 28 32 79 85 186 205 259 427 570
Other Non-Current Assets 6 15 35 7 20 5 25 51 175 187
Total Current Assets 66 66 87 124 121 216 430 457 493 792
Total Assets 91 109 155 213 232 413 659 767 1096 1549

Acutaas Chemicals Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 3 1 0 4 3 10 31 30
Cash Flow from Operating Activities 10 29 8 15 27 28 -12 66 125 118
Cash Flow from Investing Activities -14 -19 -25 -21 -24 -101 -121 -33 -365 -224
Cash Flow from Financing Activities 4 -7 15 6 0 72 140 -12 239 261
Net Cash Inflow / Outflow -0 3 -2 -0 3 -1 8 20 -1 156
Closing Cash & Cash Equivalent 0 3 1 0 4 3 10 31 30 185

Acutaas Chemicals Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.01 1.91 2.95 3.7 4.36 2.86 9.87 11.43 5.8 9.69
CEPS(Rs) 2.14 2.13 3.24 4.11 4.92 3.08 11.26 13.12 8.78 11.42
DPS(Rs) 0 0 0 0 0 0 1.5 1.5 1.5 0.75
Book NAV/Share(Rs) 4.33 6.17 8.88 12.47 16.81 8.5 71.67 81.5 91.06 79.98
Core EBITDA Margin(%) 11.83 14.43 16.22 17.64 17.12 23.53 20.22 19.88 17.91 23.05
EBIT Margin(%) 13.18 13.71 16.77 16.71 16.83 22.71 18.81 18.58 12.24 22.09
Pre Tax Margin(%) 11.52 11.66 15.06 14.72 14.5 21.06 17.58 18.19 11.42 21.47
PAT Margin (%) 8.23 7.52 9.83 9.77 11.46 15.85 13.83 13.51 6.79 15.93
Cash Profit Margin (%) 8.75 8.37 10.84 10.86 12.93 17.08 15.77 15.51 9.03 18.58
ROA(%) 13.87 12.04 13.99 12.64 12.34 16.74 13.42 11.68 5.23 12.13
ROE(%) 46.43 36.44 39.03 34.64 29.78 40.51 21.07 14.92 7.7 16.19
ROCE(%) 35.54 35.91 38.24 34.33 27.09 33.43 23.85 20.45 11.81 20.14
Receivable days 86.2 82.89 83.83 96.45 100.9 94.89 99.79 116.58 111.06 90.06
Inventory Days 46.64 44.82 45.68 50.55 69.31 60.39 60.54 68.46 70.18 61.02
Payable days 113.37 128.43 139.26 142.81 169.65 138.36 135.92 143.66 122.64 96.06
PER(x) 0 0 0 0 0 0 50.63 38.89 94.36 125.94
Price/Book(x) 0 0 0 0 0 0 6.97 5.45 6.01 15.26
Dividend Yield(%) 0 0 0 0 0 0 0.3 0.34 0.27 0.06
EV/Net Sales(x) 0.2 0.15 0.23 0.27 0.28 0.49 6.81 5.16 5.85 19.61
EV/Core EBITDA(x) 1.46 1.05 1.32 1.51 1.51 2.03 32.83 25.09 30.88 79.31
Net Sales Growth(%) 0 4.27 17.45 26.72 0.47 42.13 52.71 18.57 16.33 40.34
EBIT Growth(%) 0 8.48 43.65 26.26 1.2 91.73 26.52 17.09 -23.34 153.16
PAT Growth(%) 0 -4.8 53.51 25.95 17.92 96.57 33.24 15.77 -41.52 229.35
EPS Growth(%) 0 -4.8 54.05 25.51 17.92 -34.47 245.55 15.77 -49.26 67.16
Debt/Equity(x) 1.09 0.68 0.78 0.69 0.56 0.85 0 0.01 0.32 0.01
Current Ratio(x) 1.36 1.21 1.34 1.18 1.28 1.3 3.32 2.81 1.73 3.91
Quick Ratio(x) 0.96 0.85 0.92 0.81 0.73 0.94 2.45 2.08 1.18 3.02
Interest Cover(x) 7.92 6.67 9.79 8.39 7.22 13.77 15.27 47.5 14.79 35.76
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0.05 0

Acutaas Chemicals Shareholding Pattern

# Mar 2024 May 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 39.91 39.07 35.98 35.97 35.96 35.96 32.66 32.66 32.66 32.66
FII 8.97 10.01 12.92 13.87 15.52 16.48 16.94 16.85 16.67 19.48
DII 6.81 8.81 14.81 19.93 20.25 18.33 22.39 22.6 21.71 19.61
Public 44.31 42.12 36.29 30.23 28.27 29.23 28.01 27.89 28.96 28.24
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Acutaas Chemicals News

Acutaas Chemicals Pros & Cons

Pros

  • Company has delivered good profit growth of 42% CAGR over last 5 years
  • Debtor days have improved from 122.64 to 96.06days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 32.66%.
  • Company has a low return on equity of 13% over the last 3 years.
  • Stock is trading at 13.4 times its book value.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!